Skip to main content
German Center for Infection Research
  • Research
    • Back
    • Research Areas
    • Infrastructures
    • Working Groups
    • Projects
    • Clinical Trials
    • Publications
  • Translation
    • Back
    • Developing Medication
    • Successful Translation
    • Collaborations
    • German Centers for Health Research
  • DZIF Academy
  • Newsroom
    • Back
    • SARS-CoV-2-Research
    • News
    • Media Centre
    • Press Office
    • Events
    • Jobs
  • About us
    • Back
    • Portrait
    • DZIF Structure and Bodies
    • Partner Sites
    • Executive Board
    • Staff
    • Main Office
    • Donations
  • en
    • English
    • Deutsch

Prof. Dr. Tanja Schneider

Breadcrumb

  1. Home
  2. About us
  3. Staff
  4. Prof. Dr. Tanja Schneider
Contact
Tanja Schneider

Prof. Dr. Tanja Schneider

Deputy Coordinator Novel Antibiotics
E-Mail Send mail
Partner Site
Bonn - Köln
Institution
University of Bonn
Research Area
Novel Antibiotics

Research of the employee

Bonn - Köln | Tübingen

New anti-virulence drugs against S. aureus

In this project, the scientists have developed a monoclonal antibody directed against a resistance protein that is crucial for the virulence, i.e. infectious effect, of Staphylococcus aureus. The monoclonal antibody can restore the body's own defence and thus make the bacteria vulnerable to antibiotics.

Read more
  • Share on
    • LinkedIn
    • Twitter
Print

Sitemap

  • Research
  • Translation
  • DZIF Academy
  • Newsroom
  • About us

At one click

  • Jobs
  • Media Centre
  • Press releases
  • Press contact
  • Glossary
  • Donations

Newsletter Subscription

Contact

Main Office of the DZIF e. V.
Inhoffenstraße 7
38124 Braunschweig
​

E-Mail Send mail

Fußbereichsmenü

  • Imprint
  • Privacy policy
  • Intranet
  • Log in
  • Manage cookie consent
German Centers for Health Research
Supported by the Federal Ministry of Education and Research and the participating federal states